News
Zomedica Q4 2023 GAAP EPS $(0.02), Sales $7.337M Beat $7.000M Estimate
1 Apr 24
Earnings, Earnings Beats, News
Earnings Scheduled For April 1, 2024
1 Apr 24
Earnings
Zomedica Says Continuing Dialogue With Senior Regulatory Staff At NYSE American Regarding Next Steps To Regaining Compliance With Its Listing Standards
13 Mar 24
News
Press releases
Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024
9 Apr 24
News, Press Releases
Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity
1 Apr 24
Earnings, Press Releases
Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform
14 Mar 24
News, Press Releases
Zomedica Provides NYSE American Listing Update
13 Mar 24
News, Press Releases
Zomedica Announces Sponsorship of Educational Presentations at Fetch dvm360 Veterinary Conferences
12 Mar 24
News, Press Releases
Zomedica Announces Publication of Case Series Highlighting Success with PulseVet(R) Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working Dogs
7 Mar 24
News, Press Releases
Zomedica to Present at the Sidoti Small Cap Conference March 14, 2024
5 Mar 24
News, Press Releases
Zomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health Conferences
8 Feb 24
News, Press Releases
Leading Independent Proxy Advisory Firm Glass Lewis Recommends Zomedica Shareholders Vote for the Share Consolidation (Reverse Stock Split)
6 Feb 24
News, Press Releases
Zomedica to Host Virtual Investor Day February 13 at 3:00 p.m. ET
6 Feb 24
News, Press Releases
Open Letter to Zomedica Shareholders from your Chief Executive Officer
31 Jan 24
News, Press Releases
Zomedica to Participate in the Lytham Partners 2024 Investor Select Conference
30 Jan 24
News, Press Releases